Raily Aesthetic Medicine International Holdings Limited (HKG:2135)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1030
0.00 (0.00%)
Aug 13, 2026, 10:43 AM HKT

HKG:2135 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
189.41189.41199.34189.38164.52188.37
Revenue Growth
13.78%-4.98%5.26%15.11%-12.66%14.48%
Gross Profit
77.7177.7171.4171.4966.7869.69
Operating Income
5.185.18-18.87-22.52-20.39-19.57
Net Income
1.871.87-59.21-32.46-15.91-17.69
Earnings Per Share
0.000.00-0.11-0.08-0.04-0.04
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Aesthetic Medical Services
152.91152.91142.1174.91151.66183.71
Aesthetic Medical Equipment Products
39.2639.2659.0815.2214.211.65
Consulting Services
3.673.670.03-0.033.17
Elimination of Intersegment Sales
-6.43-6.43-1.87-0.75-1.38-0.17
Total
189.41189.41199.34189.38164.52188.37

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
57.7957.7928.8739.7978.78124.89
Total Debt
59.1559.1556.3751.7848.2267.45
Net Cash (Debt)
-1.36-1.36-27.5-11.9930.5657.44
Net Cash Growth
-----46.80%-56.88%
Net Cash Per Share
-0.00-0.00-0.05-0.030.070.14

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
36.7136.716.018.02-2.28-2.47
Capital Expenditures
-2.73-2.73-8.64-18-18.85-15.77
Free Cash Flow
33.9833.98-2.64-9.98-21.13-18.23
Free Cash Flow Growth
650.79%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
41.03%41.03%35.82%37.75%40.59%37.00%
Operating Margin
2.73%2.73%-9.47%-11.89%-12.39%-10.39%
Pretax Margin
0.01%0.01%-32.74%-18.49%-13.43%-12.18%
Profit Margin
0.99%0.99%-29.70%-17.14%-9.67%-9.39%
FCF Margin
17.94%17.94%-1.32%-5.27%-12.84%-9.68%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
27.5340.09----
P/FCF Ratio
1.522.21----
PS Ratio
0.270.400.280.961.762.67